Yusuke Yagi

KISCO Ltd. manufactures and supplies industrial chemicals, equipment, and processed goods. Its chemicals segment manufactures fat and fragrance-related compounds, organic and inorganic compounds, intermediates for pharmaceuticals and toiletries, additives, catalysts, inhibitors, and reagents. The company was founded in 1921 and is headquartered in Osaka, Japan.

ITOCHU Technology Ventures, Inc. (Itochu Technology Ventures) is a venture capital arm of ITOCHU Corp. headquartered in Tokyo, Japan. The firm was founded in 2000 by ITOCHU Corp.

University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan.

MiRTeL Co. Ltd. engages in the business of gene testing services. Its services include research and development of health diagnostic systems; clinical examination and health related materials to medical care; sale of medical devices; clinical testing and clinical diagnostic services; planning of medical and information systems related to clinical testing; manufacturing, sale, import and export of pharmaceutical products and health foods; collection and delivery of reagents, containers and materials; manufacture and sale of DNA measuring kits; and all types of businesses related to clinical laboratories. The company was founded on September 3, 2012 and is headquartered in Hiroshima, Japan.

LeapMind, Inc. is a holding company that develops photo analysis technology. Its products include Black Star, Monolith, Deep Insight, and Ingrid. The company was founded by Soichi Matsuda on December 25, 2012 and is headquartered in Tokyo, Japan.

J-Pharma Co. Ltd. develops pharmaceutical products. It develops therapeutics and diagnostic agents for treatment of cancer. The company was founded in 2005 and is headquartered in Yokohama, Japan.

The Japanese company has a wealth of experience in micro-biome research and have obtained high-quality microbial genome data from various samples. The company is based in Tokyo, Japan. The company strategically combines their own single-cell analysis technology, bit-map®, to realize the next-generation microbiome analysis that approaches the essence of microbial functions. The company also uses the microbial genomic information owned by bitBiome to provide new knowledge for research and development promoted by joint partners and customers. The company was founded by Yoshihito Daimon, Masahito Hosokawa. Kimihiko Sato has been the CEO of the company since 2020.